One sixth of Amazonian tree diversity is dependent on river floodplains

Amazonia's floodplain system is the largest and most biodiverse on Earth. Although forests are crucial to the ecological integrity of floodplains, our understanding of their species composition and how this may differ from surrounding forest types is still far too limited, particularly as changing inundation regimes begin to reshape floodplain tree communities and the critical ecosystem functions they underpin. Here we address this gap by taking a spatially explicit look at Amazonia-wide patterns of tree-species turnover and ecological specialization of the region's floodplain forests. We show that the majority of Amazonian tree species can inhabit floodplains, and about a sixth of Amazonian tree diversity is ecologically specialized on floodplains. The degree of specialization in floodplain communities is driven by regional flood patterns, with the most compositionally differentiated floodplain forests located centrally within the fluvial network and contingent on the most extraordinary flood magnitudes regionally. Our results provide a spatially explicit view of ecological specialization of floodplain forest communities and expose the need for whole-basin hydrological integrity to protect the Amazon's tree diversity and its function.Naturali

Mapping density, diversity and species-richness of the Amazon tree flora

Using 2.046 botanically-inventoried tree plots across the largest tropical forest on Earth, we mapped tree species-diversity and tree species-richness at 0.1-degree resolution, and investigated drivers for diversity and richness. Using only location, stratified by forest type, as predictor, our spatial model, to the best of our knowledge, provides the most accurate map of tree diversity in Amazonia to date, explaining approximately 70% of the tree diversity and species-richness. Large soil-forest combinations determine a significant percentage of the variation in tree species-richness and tree alpha-diversity in Amazonian forest-plots. We suggest that the size and fragmentation of these systems drive their large-scale diversity patterns and hence local diversity. A model not using location but cumulative water deficit, tree density, and temperature seasonality explains 47% of the tree species-richness in the terra-firme forest in Amazonia. Over large areas across Amazonia, residuals of this relationship are small and poorly spatially structured, suggesting that much of the residual variation may be local. The Guyana Shield area has consistently negative residuals, showing that this area has lower tree species-richness than expected by our models. We provide extensive plot meta-data, including tree density, tree alpha-diversity and tree species-richness results and gridded maps at 0.1-degree resolution

Integrated global assessment of the natural forest carbon potential

Forests are a substantial terrestrial carbon sink, but anthropogenic changes in land use and climate have considerably reduced the scale of this system1. Remote-sensing estimates to quantify carbon losses from global forests2,3,4,5 are characterized by considerable uncertainty and we lack a comprehensive ground-sourced evaluation to benchmark these estimates. Here we combine several ground-sourced6 and satellite-derived approaches2,7,8 to evaluate the scale of the global forest carbon potential outside agricultural and urban lands. Despite regional variation, the predictions demonstrated remarkable consistency at a global scale, with only a 12% difference between the ground-sourced and satellite-derived estimates. At present, global forest carbon storage is markedly under the natural potential, with a total deficit of 226 Gt (model range = 151–363 Gt) in areas with low human footprint. Most (61%, 139 Gt C) of this potential is in areas with existing forests, in which ecosystem protection can allow forests to recover to maturity. The remaining 39% (87 Gt C) of potential lies in regions in which forests have been removed or fragmented. Although forests cannot be a substitute for emissions reductions, our results support the idea2,3,9 that the conservation, restoration and sustainable management of diverse forests offer valuable contributions to meeting global climate and biodiversity targets

Effect Of A Nanostructured Dendrimer-naloxonazine Complex On Endogenous Opioid Peptides μ 1 Receptor-mediated Post-ictal Antinociception

The aim of this study was to investigate the capacity of the host dendrimer DAB-Am-16 as a drug carrier to reduce the time required for the encapsulated naloxonaxine to establish an irreversible covalent bond with μ 1-opioid receptor (resulting in a pharmacologically selective effect). The efficacy of dendrimer-naloxonazine nanocomplex (DNC) was studied in antinociception induced by convulsions elicited by intraperitoneal (IP) administration of pentylenetetrazole, and analgesia was measured by the tail-flick test. We found that animals showed increased tail-flick latencies following convulsions. Furthermore, acute pre-treatment (10 minutes) with DNC, but not with naloxonazine alone, antagonized post-ictal analgesia in comparison with control pre-treatment. However, naloxonazine treatment 24 hours before PTZ decreased post-ictal antinociception, but DNC failed to antagonize tonic-clonic seizure-induced analgesia. In addition, according to Racine's index of seizure severity, naloxonazine, DAB-Am-16 dendrimer or DNC did not influence seizure severity when administered either 10 minutes or 24 hours before PTZ. From the Clinical Editor: This study characterizes the effect of a dendrimer-naloxonazine complex on μ1 receptor-mediated post-ictal antinociception in an animal model of seizure disorder. © 2011 Elsevier Inc.76871880Lindsey, J.S., Self-Assembly in synthetic routes to molecular devices - Biological principles and chemical perspectives - A Review (1991) New J Chem, 15, pp. 153-180Newkome, G.R., Moorefield, C.N., Vögtle, F., (1996) Dendritic molecules: concepts, synthesis, perspectives, , Wiley VCH, Weinheim, GermanyFréchet, J.M.J., Hawker, C.J., (1996) Comprehensive Polymer Science. 2nd supplement, , Pergamon, Elsevier Science, Oxford, G. Allen (Ed.)Tomalia, D.A., Naylor, A.M., Goddard, W.A., Starburst dendrimers-molecular-level control of size, shape, surface-chemistry, topology, and flexibility from atoms to macroscopic matter (1990) Angew Chem Int Ed Engl, 29, pp. 138-175Grayson, M., Fréchet, J.M.J., Convergent dendrons and dendrimers: From synthesis to applications (2001) Chem Rev, 101, pp. 3819-3867Chen, H., Banaszak Holl, M., Orr, B.G., Majoros, I., Clarkson, B.H., Interaction of dendrimers (artificial proteins) with biological hydroxyapatite crystals (2003) J Dent Res, 82, pp. 443-448Newkome, G.R., Yao, Z.Q., Baker, G.R., Gupta, V.K., Cascade molecules: a new approach to micelles. A [27]-Arborol (1985) J Org Chem, 50 (11), pp. 2003-2004Hawker, C.J., Fréchet, J.M.J., Preparation of polymers with controlled molecular architecture - A new convergent approach to dendritic macromolecules (1990) J Am Chem Soc, 112, pp. 7638-7647Duncan, R., Izzo, L., Dendrimer biocompatibility and toxicity (2005) Adv Drug Del Rev, 57, pp. 2215-2237Esfand, R., Tomalia, D.A., Poly(amidoamine) PAMAM dendrimers: from biomimicry to drug delivery andbiomedical applications (2001) Drug Discov Today, 6, pp. 427-436Cloninger, M.J., Biological applications of dendrimers (2002) Curr Opin Chem Biol, 6, pp. 742-748Guo, C.Y., Wang, H., Lin, Y.H., Cai, Q.L., Application of Starburst (TM) PAMAM dendrimers as DNA carriers in vitro (2004) Prog Biochem Biophys, 31, pp. 804-811Taylor, E.P., Moore, R.B., Incorporation of poly(propylene imine) dendrimers into PFSI membranes for modified ionic transport (1998) Abstracts Papers Am Chem Soc, 215, pp. U380-U381Anthopoulos, T.D., Markham, J.P.J., Namdas, E.B., Samuel, I.D.W., Chun, L.S., Paul, L., Highly efficient single-layer dendrimer light-emitting diodes with balanced charge transport (2003) Appl Phys Lett, 82, pp. 4824-4826Bar, G., Rubin, S., Cutts, R.W., Taylor, T.N., Thomas, A.J., Dendrimer-modified silicon oxide surfaces as platforms for the deposition of gold and silver colloid monolayers: preparation method, characterization, and correlation between microstructure and optical properties (1996) Langmuir, 12, pp. 1172-1179Lim, Y.B., Kim, T., Lee, J.W., Kim, S., Kim, H.J., Kim, K., Park, J.S., Self-assembled ternary complex of cationic dendrimer, cucurbituril, and DNA: noncovalent strategy in developing a gene delivery carrier (2002) Bioconjug Chem, 13, pp. 1181-1185Zinselmeyer, B.H., Mackay, S.P., Andreas, G., Uchegbu, J.F., The lower-generation polypropylenimine dendrimers are effective gene-transfer agents (2002) Pharm Res, 19, pp. 960-967Hahn, E.F., Pasternak, G.W., Naloxonazine, a potent, long-lasting inhibitor of opiate binding-sites (1982) Life Sci, 31, pp. 1385-1388Johnson, N., Pasternak, G.W., Binding of [ 3H]Naloxonazine to rat brain membranes (1984) Mol Pharmacol, 26, pp. 477-483Ling, G.S.F., Simantov, R., Clark, J.A., Pasternak, G.W., Naloxonazine actions in vivo (1986) Eur J Pharmacol, 129, pp. 33-38Osaki, M.Y., Castellan-Baldan, L., Calvo, F., Carvalho, A.D., Felippotti, T.T., De Oliveira, R., Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of μ 1- and k{cyrillic}-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus (2003) Brain Res, 2, pp. 179-192Ribeiro, S.J., Ciscato, J.G., De Oliveira, R., De Oliveira, R.C., D'Ângelo-Dias, R., Carvalho, A.D., Functional and ultrastructural neuroanatomy of interactive intratectal/tectonigral mesencephalic opioid inhibitory links and nigrotectal GABAergic pathways: involvement of GABA A and μ 1-opioid receptors in the modulation of panic-like reactions elicited by electrical stimulation of the dorsal midbrain (2005) J Chem Neuroanat, 30, pp. 184-200Myslobodsky, M.S., Mintz, M., Kofman, O., Pharmacologic analysis of the postictal immobility syndrome in the rat (1981) Pharmacol Biochem Behav, 15, pp. 93-100Myslobodsky, M., Kofman, O., Mintz, M., Convulsant-specific architecture of the postictal behavior syndrome in the rat (1981) Epilepsia, 22, pp. 559-568Guieu, R., Mesdjian, E., Roger, J., Dano, P., Pouget, J., Serratice, G., Nociceptive threshold in patients with epilepsy (1992) Epilepsy Res, 12, pp. 57-61Coimbra, N.C., Castro-Souza, C., Segato, E.N., Nora, J.E.P., Herrero, C.F.P.S., Tedeschi-Filho, W., Post-ictal analgesia: involvement of opioid, serotoninergic and cholinergic mechanisms (2001) Brains Res, 888, pp. 314-320Coimbra, N.C., Freitas, R.L., Savoldi, M., Castro-Souza, C., Segato, E.N., Kishi, R., Opioid neurotransmission in the post-ictal analgesia: involvement of μ 1-opioid receptor (2001) Brain Res, 903, pp. 216-221de Oliveira, R.C., de Oliveira, R., Ferreira, C.M.R., Coimbra, N.C., Involvement of 5-HT 2 serotonergic receptors of the nucleus raphe magnus and nucleus reticularis gigantocellularis/paragigantocellularis complex neural networks in the antinociceptive phenomenon that follows the post-ictal immobility syndrome (2006) Exp Neurol, 201, pp. 144-153Freitas, R.L., Ferreira, C.M.R., Ribeiro, S.J., Carvalho, A.D., Elias-Filho, D.H., Garcia-Cairasco, N., Intrinsic neural circuits between dorsal midbrain neurons that control fear-induced responses and seizure activity and nuclei of the pain inhibitory system elaborating post-ictal antinociceptive processes: a functional neuroanatomical and neuropharmacological study (2005) Exp Neurol, 191, pp. 225-242de Freitas, R.L., de Oliveira, R.C., de Carvalho, A.D., Felippotti, T.T., Bassi, G.S., Elias-Filho, D.H., Role of muscarinic and nicotinic cholinergic receptors in an experimental model of epilepsy-induced analgesia (2004) Pharmacol Biochem Behav, 79, pp. 367-376Prado, W.A., Roberts, M.H.T., An assessment of the antinociceptive and aversive effects of stimulating identified sites in the rat brain (1985) Brain Res, 340, pp. 219-228Racine, R.J., Modification of seizure activity by electrical stimulation. II. Motor seizure (1972) Electroencephalogr Clin Neurophysiol, 32 (3), pp. 281-294Gajbhiye, V., Kumar, P.V., Tekade, R.K., Jain, N.K., PEGylated PPI Dendritic architectures for sustained delivery of H 2 receptor antagonist (2009) Eur J Med Chem, 44 (3), pp. 1155-1166Grillo, R., de Melo, N.F.S., Moraes, C.M., de Lima, R., Menezes, C.M.S., Ferreira, E.I., Study of the interaction between hydroxymethylnitrofurazone and 2-hydroxypropyl-β-cyclodextrin (2008) J Pharm Biom Anal, 47 (2), pp. 295-302Moraes, C.M., Abrami, P., de Araújo, D.R., Braga, A.F.A., Issa, M.G., Ferraz, H.G., Caracterization of lidocaine: hydroxypropyl-β-cyclodextrin (2007) J Incl Phenom Macrocycl Chem, 57, pp. 313-316Paavola, A., Yliruusi, J., Kajimoto, Y., Kalso, E., Wahlström, T., Rosenberg, P., Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block (1995) Pharm Res, 12, pp. 1997-2002Na, M., Yiyun, C., Tongwen, X., Yang, D., Xiaomin, W., Zhenwei, L., Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies (2006) Europ J Medic Chem, 41, pp. 670-674Dickenson, A.H., Oliveras, J.L., Besson, J.M., Role of the nucleus raphe magnus in opiate analgesia as studied by the microinjection technique in the rat (1979) Brain Res, 170, pp. 95-111Le Bars, D., Gozariu, M., Cadden, S.W., Animal models of nociception (2001) Pharmacol Rev, 53, pp. 597-652Rajendiran, N., Swaminathan, M., Luminescence characteristics of 4,4'-diaminodiphenyl methane in different solvents and at various pH (1996) Spectrochim Acta Part A, 52 (13), pp. 1785-1792Husain, N., Ndou, T.T., Muñoz de la Peña, A., Warner, I.M., Complexation of Doxorubicin with b- and g-Cyclodextrins (1992) Appl Spectrosc, 46, pp. 652-658Coimbra, N.C., Osaki, M.Y., Einchenberger, G.C.D., Ciscato, J.G., Jucá, C.E.B., Biojone, C.R., Effects of opioid receptor blockade on defensive behavior elicited by electrical stimulation of the aversive substrates of the inferior colliculus in Rattus novergicus (Rodentia, Muridae) (2000) Psychopharmacology (Berl), 152, pp. 422-430Abbott, F.V., Melzack, R., Analgesia produced by stimulation of limbic structures and its relation to epileptiforme after-discharges (1978) Exp Neurol, 62, pp. 720-734Caldecott-Hazard, S., Liebeskind, J.C., Test-specific analgesia elicited by kindled seizures in rats (1982) Brain Res, 251, pp. 196-199Caldecott-Hazard, S., Shavit, Y., Berman, D.W., Liebeskind, J.C., Seizure induced opioid and non-opioid analgesia in rats (1982) Proc West Pharmacol Soc, 25, pp. 107-111Freitas, R.L., Bassi, G.S., Oliveira, A.M., Coimbra, N.C., Serotonergic neurotransmission in the dorsal raphe nucleus recruits in situ 5-HT2A/2C receptors to modulate the post-ictal antinociception (2008) Exp Neurol, 213, pp. 410-418Freitas, R.L., Ferreira, C.M.R., Urbina, M.A.C., Mariño, A.U., Carvalho, A.D., Butera, G., 5-HT1A/1B, 5-HT6, and 5-HT7 serotonergic receptors recruitment in tonic-clonic seizure induced antinociception: role of dorsal raphe nucleus (2009) Exp Neurol, 217, pp. 16-24Ito, M., Nakamura, F., Honma, H., Takeda, Y., Kobayashi, R., Miyamoto, T., A comparison of post-ictal headache between patients with occipital lobe epilepsy and temporal lobe epilepsy (1999) Seizure, 8, pp. 343-346Ito, M., Nakamura, F., Honma, H., Takeda, Y., Kobayashi, R., Miyamoto, T., Clinical factors associated with post-ictal headache in patients with epilepsy (2000) Acta Neurol Scand, 102, pp. 129-131Ito, M., Adachi, N., Nakamura, F., Koyama, T., Okamura, T., Kato, M., Characteristics of postictal headache in patients with temporal epilepsy (2004) Cephalalgia, 24, pp. 23-28Yamane, L.E., Montenegro, M.A., Guerreiro, M.M., Comorbidity headache and epilepsy in childhood (2004) Neuropediatrics, 35, pp. 99-10

Transient decrease in nociceptor GRK2 expression produces long-term enhancement in inflammatory pain

In heterozygous mice, attenuation of G-protein-coupled receptor kinase 2 (GRK2) level in nociceptors is associated with enhanced and prolonged inflammatory hyperalgesia. To further elucidate the role of GRK2 in nociceptor function we reversibly decreased GRK2 expression using intrathecal antisense oligodeoxynucleotide (AS-ODN). GRK2 AS-ODN administration led to an enhanced and prolonged hyperalgesia induced by prostaglandin E 2, epinephrine and carrageenan. Morover, this effect persisted unattenuated 2 weeks after the last dose of antisense, well after GRK2 protein recovered, suggesting that transient attenuation of GRK2 produced neuroplastic changes in nociceptor function. Unlike hyperalgesic priming induced by transient attenuation of GRK2 produced neuroplastic changes in nociceptor function. Unlike hyperalgesic priming induced by transient activation of protein kinase C epsilon (PKCε), (Aley et al., 2000, Parada et al., 2003b), the enhanced and prolonged hyperalgesia following attenuation of GRK2 is PKCε- and cytoplasmic polyadenylation element binding protein (CPEB)-independent and is protein kinase A (PKA)- and Src tyrosine kinase (Src)-dependent. Finally, rats treated with GRK2 AS-ODN exhibited enhanced and prolonged hyperalgesia induced by direct activation of second messengers, adenyl cyclase, Epac or PKA, suggesting changes downstream of G-protein-coupled receptors. Because inflammation can produce a decrease in GRK2, such a mechanism could help explain a predilection to develop chronic pain, after resolution of acute inflammation